眼科门诊糖尿病患者血压评估研究
这项前瞻性病例系列研究在单中心视网膜门诊对172例糖尿病成人进行诊室血压测量和结构化问卷调查,发现52.9%为2级高血压、10.5%达高血压危象标准,即使在已有高血压诊断者中仍有79.9%血压未达标,提示眼科门诊机会性血压筛查可行且能识别可干预的心血管风险。
要点
- 糖尿病成人眼科就诊者中52.9%为2级高血压,10.5%达高血压危象标准。
- 144例已知高血压者中91.0%接受治疗,但79.9%仍为1级及以上高血压。
- 28例无高血压病史者中85.7%血压高于正常,35.7%为2级高血压。
核心结论
- 在单中心病例系列中,糖尿病患者的未控制或既往未识别高血压高度流行,即使已参与常规医疗随访者亦然。
- 眼科门诊机会性血压筛查看似可行,可能识别可干预的心血管风险。
研究设计与样本
- 前瞻性病例系列,2024年7月至2024年8月在单中心学术视网膜门诊开展,数据分析于2025年10月至2025年12月进行。
- 纳入172例18岁及以上1型或2型糖尿病成人,接受诊室血压测量并完成结构化问卷,另从电子病历获取临床和眼科数据。
主要发现
- 172例患者平均(SD)年龄66.6(13.9)岁,女性84例(48.8%)。
- 14例(8.1%)血压正常,91例(52.9%)为2级高血压,18例(10.5%)符合高血压危象标准。
- 144/172例(83.7%)既往有高血压诊断,其中131/144例(91.0%)接受降压治疗。
- 28例无已知高血压者中,24/28例(85.7%)血压高于正常,包括10/28例(35.7%)为2级高血压和3/28例(10.7%)为高血压危象。
- 144例已诊断高血压者中100例(69.4%)自认为控制良好或极好,但115例(79.9%)血压为1级及以上高血压。
关键数值与推荐
- 血压分级采用2017年美国心脏病学会/美国心脏协会标准,分类取决于收缩压和舒张压两者。
- 正常血压定义为收缩压低于120 mm Hg且舒张压低于80 mm Hg。
- 血压升高定义为收缩压120至129 mm Hg且舒张压低于80 mm Hg。
- 1级高血压定义为收缩压130至139 mm Hg或舒张压80至89 mm Hg;2级高血压定义为收缩压140 mm Hg及以上或舒张压90 mm Hg及以上;高血压危象定义为收缩压高于180 mm Hg和/或舒张压高于120 mm Hg。
- 测量后103/172例(59.9%)被建议联系其初级保健临床医生,20/172例(11.6%)需要加急随访。
临床怎么用
- 眼科门诊对糖尿病就诊者可考虑开展机会性血压测量,以识别未控制或未识别的高血压。
- 对血压明显升高者,可建议联系初级保健临床医生或安排加急随访。
局限性
- 本研究为单中心学术视网膜门诊的前瞻性病例系列,样本量为172例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hypertension is a major modifiable risk factor for diabetic retinopathy progression but may not be assessed routinely during ophthalmology visits. OBJECTIVE: To evaluate prevalence of elevated or uncontrolled blood pressure (BP) among adults with diabetes presenting for ophthalmologic care and patient attitudes toward in-clinic screening. DESIGN, SETTING, AND PARTICIPANTS: This prospective case series was conducted from July 2024 to August 2024 at a single academic retina clinic. Data were analyzed from October 2025 to December 2025. Adults aged 18 years or older with type 1 or type 2 diabetes underwent in-clinic BP measurement and completed a structured survey on hypertension history, monitoring, perceived control, and knowledge. Additional clinical and ophthalmic data were obtained from electronic medical records. MAIN OUTCOMES AND MEASURES: The primary outcome was the prevalence of elevated BP and hypertension stage by 2017 American College of Cardiology/American Heart Association criteria, in which classification depends on both systolic and diastolic values. Normal BP was defined as systolic BP less than 120 mm Hg and diastolic BP less than 80 mm Hg; elevated, systolic BP 120 to 129 mm Hg and diastolic BP less than 80 mm Hg; stage 1 hypertension, systolic BP 130 to 139 mm Hg or diastolic BP 80 to 89 mm Hg; stage 2 hypertension, systolic BP of 140 mm Hg or higher or diastolic BP of 90 mm Hg or higher; and hypertensive crisis, systolic BP higher than 180 mm Hg and/or diastolic BP higher than 120 mm Hg. RESULTS: Among 172 patients (mean [SD] age, 66.6 [13.9] years; 84 female patients [48.8%]), 14 (8.1%) had normal blood pressure, 91 (52.9%) had stage 2 hypertension, and 18 (10.5%) met criteria for hypertensive crisis. A prior diagnosis of hypertension was present in 144 of 172 patients (83.7%); among these, 131 of 144 patients (91.0%) were receiving antihypertensive therapy. Among 28 patients without known hypertension, 24 of 28 (85.7%) had above-normal blood pressure, including 10 of 28 (35.7%) with stage 2 hypertension and 3 of 28 (10.7%) in hypertensive crisis. Although 100 of 144 patients with diagnosed hypertension (69.4%) perceived their control as good or excellent, 115 (79.9%) had BP stage 1 or greater. Following measurement, 103 of 172 patients (59.9%) were advised to contact their primary care clinician, and 20 of 172 (11.6%) required expedited follow-up. CONCLUSIONS AND RELEVANCE: In this single-center case series, uncontrolled or previously unrecognized hypertension was highly prevalent among patients with diabetes, even among those engaged in routine medical follow-up. Opportunistic BP screening in ophthalmology clinics appears feasible and may identify actionable cardiovascular risk.
引用
- Samayamanthula S, Williams J, Markowski A, et al. Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes. JAMA Ophthalmol. 2026. PMID: 42348192. doi:10.1001/jamaophthalmol.2026.2245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。